MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-20-0031022
Adroit Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹80.51 Cr
▲ 2% YoY
Net profit · FY 2024
₹1.19 Cr
Net margin 1.5%
EBITDA · FY 2024
₹3.84 Cr
EBITDA margin 4.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹90,000
Issued & subscribed
Open charges
₹40.07 Cr
Satisfied ₹16.36 Cr
Company age
49 yrs
Est. 1977
Employees · EPFO
52
Provident fund records
About Adroit Pharmaceuticals Private Limited
Data last updated:
Adroit Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 1977 and has been in existence for over 49 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1977PTC019620. Its GSTIN is 27AAACA6824F1ZW (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹90,000. It is led by directors including Cheturam Hassanand Kukreja and Abhimanyu Hassanand Kukreja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 1003 Eternity A Wing Raheja Reflections Thakur Village Road Kandivali (East), Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2024, the company reported a revenue of ₹80.51 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 1.5%) and EBITDA of ₹3.84 Cr (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 7% over five years.
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Adroit Pharma. As per MCA filings, the company has open charges of ₹40.07 Cr and satisfied charges of ₹16.36 Cr on record. Court records list 64 cases involving the company, including 24 filed by the company and 41 filed against it; 16 cases are pending.
Adroit Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0031022). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adroitpharmachem.com.
Company details
CIN U24239MH1977PTC019620
Registration Number 019620
Incorporation Date 25 April 1977
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-20-0031022
Key People
Cheturam Hassanand Kukreja Director Abhimanyu Hassanand Kukreja Director Bhupendra Abhimanyu Kukreja Director Recognitions & Rankings of Adroit Pharmaceuticals
Contact details
Adroit Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is adroitpharmachem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 1003 Eternity A Wing Raheja Reflections Thakur Village Road Kandivali (East), Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adroit Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Adroit Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Adroit Pharmaceuticals operates one associated brand: Adroit Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports API, pharmaceutical intermediates, and speciality chemicals globally. | adroitpharmachem.com |
Business activity
The main business activity of Adroit Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adroit Pharmaceuticals Private Limited, buy the company report.
Financials of Adroit Pharmaceuticals Private Limited
FY 2025 filings availableAdroit Pharmaceuticals Private Limited reported revenue of ₹80.51 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹80.51 Cr ▲ 2%
Net profit · FY 2024
₹1.19 Cr margin 1.5%
EBITDA · FY 2024
₹3.84 Cr margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 2%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 11%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 2% growth in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.84 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adroit Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adroit Pharmaceuticals Private Limited
Adroit Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Cheturam Hassanand Kukreja | Director | 19 Oct 1981 | 45 Years 0 Months | Current |
| Abhimanyu Hassanand Kukreja Also directs: Taap Choice Foods Private Limited | Director | 24 Apr 1979 | 47 Years 6 Months | Current |
| Bhupendra Abhimanyu Kukreja Also directs: Kartik Shelters LLP, Unijules Foods Private Limited, Household Pharmaceuticals Limited and 5 more | Director | 10 Mar 1997 | 29 Years 7 Months | Current |
| Sanjay Kukreja Cheturam Also directs: Household Pharmaceuticals Limited, Haseeb Pharmaceuticals Private Limited, Heil German Pharmaceuticals Private Limited and 4 more | Director | 10 Mar 1997 | 29 Years 7 Months | Current |
| Ghanshyamdas Hassanand Kukreja | Director | 19 Oct 1981 | 45 Years 0 Months | Current |
Peer comparison
Adroit Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Food and Beverages industry (Food and Beverages Retail and Distribution, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Endoc Lifecare Private Limited | ₹80.74 Cr (FY 2025) | -8.0% | Rajkot, Gujarat, India | |||
| Nikvin Healthcare (India) Private Limited | ₹80.65 Cr (FY 2025) | 42.0% | New Delhi, Delhi, India | |||
| Adroit Pharmaceuticals Private Limitedthis company | ₹80.51 Cr (FY 2024) | ₹1.19 Cr | 1.5% | 2.0% | 52 | Mumbai, Maharashtra, India |
| Salud Care (India) Limited | ₹80.41 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Adroit Pharmaceuticals Private Limited, buy the company report.
Auditor
Adroit Pharmaceuticals Private Limited is audited by SATISH GIDWANI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATISH GIDWANI & CO. | FY 2023 | 129457W |
Shareholding
The shareholding of Adroit Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adroit Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40.07 Cr
Satisfied charges
₹16.36 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2022 | 100558429 | Others | ₹15 Cr | Open | |
| 16 Sep 2021 | 100488736 | Axis Bank Limited | ₹22.49 Cr | Open | |
| 20 Jun 2020 | 100355573 | Others | ₹30 Lakh | Open | |
| 31 Oct 2019 | 100303197 | Others | ₹2.28 Cr | Open | |
| 09 Jun 2020 | 100339573 | Others | ₹94.27 Lakh | Satisfied |
To see the full charge records of Adroit Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Adroit Pharmaceuticals Private Limited has 64 court cases on record: 24 filed by Adroit Pharmaceuticals, 41 filed against it. 16 cases are pending and 48 are disposed.
Total cases
64
Filed by the company
24
Filed against the company
41
Pending
16
Disposed
48
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 40 | 35 | 12 |
| High courts | 15 | 0 | 4 |
| NCLAT | 6 | 3 | 0 |
| Supreme Court | 2 | 2 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 64)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company by Dots Lifescience Pvt. Ltd. | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against Unijules Life Sciences Limited and 3 others | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Unijules Life Sciences Limited and 3 others | Disposed |
| NCLAT, Chairperson Court | Tribunal matter | Filed against the company by Asset Reconstruction Company India Ltd | Disposed |
| Supreme Court | Court case (1429-Criminal Matters : Matters for/against quashing of criminal proceedings) | Filed against the company by G.H. Kukreja Managing Director, M/S. Adroit Pharmaceuticals Pvt. Ltd. 46, Garbia Maidan, Basti Precinct, Nagpur-440008 ,Nagpur , Maharashtra | Disposed |
To see the full case history of Adroit Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adroit Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Adroit Pharmaceuticals Private Limited has a workforce of 52 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
52
Active EPFO establishments
1
Employee growth
-3.7%
GST
Adroit Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA6824F1ZW | Maharashtra | Active | 01 Jul 2017 |
| 09AAACA6824F1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adroit Pharmaceuticals Private Limited, buy the company report.
Recent activity
Adroit Pharmaceuticals Private Limited has 9 board changes on record since 1979: 7 appointments and 2 cessations. The latest: Deepak Arjundas Kukreja ceased to be Director on 22 Apr 2019.
AGM
Adroit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 2,249.00 Lakh registered on 16 Sep 2021 with Charge ID 100488736 was modified on 30 May 2025.
Filing
Adroit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others amounted to Rs. 1,500.00 Lakh with Charge ID 100558429 was registered on 23 Mar 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 2,249.00 Lakh with Charge ID 100488736 was registered on 16 Sep 2021.
Charges
A charge registered on 09 Jun 2020 via Charge ID 100339573 with Others was fully satisfied on 14 Sep 2021.
Charges
A charge registered on 11 Apr 2000 via Charge ID 80003212 with Others was fully satisfied on 14 Sep 2021.
Charges
A charge with Others of Rs. 1,475.00 Lakh registered on 11 Apr 2000 with Charge ID 80003212 was modified on 29 Jan 2021.
Charges
A charge registered on 25 Feb 2019 via Charge ID 100239887 with Others was fully satisfied on 21 Jan 2021.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100355573 was registered on 20 Jun 2020.
Charges
A charge with Others amounted to Rs. 94.27 Lakh with Charge ID 100339573 was registered on 09 Jun 2020.
Charges
A charge with Others amounted to Rs. 228.00 Lakh with Charge ID 100303197 was registered on 31 Oct 2019.
14 earlier events are in the company report.
Frequently asked questions
Adroit Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 1977 (49+ years old) and is registered under CIN U24239MH1977PTC019620.
Adroit Pharmaceuticals has 5 current directors:
- Cheturam Hassanand Kukreja - Director
- Abhimanyu Hassanand Kukreja - Director
- Bhupendra Abhimanyu Kukreja - Director
- Sanjay Kukreja Cheturam - Director
- Ghanshyamdas Hassanand Kukreja - Director
The latest financial statements of Adroit Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Adroit Pharmaceuticals is 27AAACA6824F1ZW, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAACA6824F1ZU (Uttar Pradesh).
The CIN (Corporate Identification Number) of Adroit Pharmaceuticals is U24239MH1977PTC019620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adroit Pharmaceuticals has 64 court cases on record: 24 filed by the company and 41 filed against it. 16 are pending. Most are in the district courts.
Adroit Pharmaceuticals was incorporated on 25 April 1977, making it 49+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Adroit Pharmaceuticals by revenue are Endoc Lifecare Private Limited, Nikvin Healthcare (India) Private Limited, Salud Care (India) Limited, all in the Food and Beverages industry (Food and Beverages Retail and Distribution, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Deepak Arjundas Kukreja ceased to be Director on 22 Apr 2019. Anil Arjundas Kukreja ceased to be Director on 15 Sep 2012. Deepak Arjundas Kukreja was appointed as Director on 21 Apr 2004. Adroit Pharmaceuticals has 9 board changes on record in total.
Yes, Adroit Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-20-0031022).
Adroit Pharmaceuticals can be reached through the website adroitpharmachem.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages